Gerald T. Stanewick
Keine laufenden Positionen mehr
Profil
Gerald T.
Stanewick has been a Director of Nastech Pharmaceutical Co., Inc. since June 2004.
Until his retirement in 2003, Mr. Stanewick worked on Wall Street for more than 30 years.
From 1991 to 2003, he was an Institutional Bond Salesman of Spear Leeds & Kellogg.
Mr. Stanewick worked at Wertheim Schroder & Co. from 1981 to 1991, including as Partner in charge of the Bond Department for the San Francisco Office from 1986 to 1991.
Prior to joining Wertheim Schroder, Mr. Stanewick was a Government Bond Trader of Bear Stearns.
From 1976 to 1980, he was a Government Bond Trader of Mitchell Hutchins.
From 1972 to 1976, Mr. Stanewick was a Securities Analyst of Goldman Sachs.
He received a BA degree in Economics from St. Michael's College in Burlington, Vermont.
Ehemalige bekannte Positionen von Gerald T. Stanewick
Unternehmen | Position | Ende |
---|---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Direktor/Vorstandsmitglied | - |
Ausbildung von Gerald T. Stanewick
University of St. Michael's College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |